Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”

Guardado en:
Detalles Bibliográficos
Autores principales: Kazuki Takada, MD, PhD, Shinkichi Takamori, MD, PhD, Naoko Miura, MD, PhD, Yasunori Shikada, MD, PhD, Mototsugu Shimokawa, PhD
Formato: article
Lenguaje:EN
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://doaj.org/article/4f3dc4df4968481ebf63a5bf4c465a89
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4f3dc4df4968481ebf63a5bf4c465a89
record_format dspace
spelling oai:doaj.org-article:4f3dc4df4968481ebf63a5bf4c465a892021-12-02T05:03:46ZCorrespondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”2666-364310.1016/j.jtocrr.2021.100238https://doaj.org/article/4f3dc4df4968481ebf63a5bf4c465a892021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2666364321000977https://doaj.org/toc/2666-3643Kazuki Takada, MD, PhDShinkichi Takamori, MD, PhDNaoko Miura, MD, PhDYasunori Shikada, MD, PhDMototsugu Shimokawa, PhDElsevierarticleNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJTO Clinical and Research Reports, Vol 2, Iss 11, Pp 100238- (2021)
institution DOAJ
collection DOAJ
language EN
topic Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Kazuki Takada, MD, PhD
Shinkichi Takamori, MD, PhD
Naoko Miura, MD, PhD
Yasunori Shikada, MD, PhD
Mototsugu Shimokawa, PhD
Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
format article
author Kazuki Takada, MD, PhD
Shinkichi Takamori, MD, PhD
Naoko Miura, MD, PhD
Yasunori Shikada, MD, PhD
Mototsugu Shimokawa, PhD
author_facet Kazuki Takada, MD, PhD
Shinkichi Takamori, MD, PhD
Naoko Miura, MD, PhD
Yasunori Shikada, MD, PhD
Mototsugu Shimokawa, PhD
author_sort Kazuki Takada, MD, PhD
title Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_short Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_full Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_fullStr Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_full_unstemmed Correspondence Regarding “Tolerability of Coronavirus Disease 2019 Vaccines BNT162b2 and mRNA-1273 in Patients With Thymic Epithelial Tumors”
title_sort correspondence regarding “tolerability of coronavirus disease 2019 vaccines bnt162b2 and mrna-1273 in patients with thymic epithelial tumors”
publisher Elsevier
publishDate 2021
url https://doaj.org/article/4f3dc4df4968481ebf63a5bf4c465a89
work_keys_str_mv AT kazukitakadamdphd correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT shinkichitakamorimdphd correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT naokomiuramdphd correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT yasunorishikadamdphd correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
AT mototsugushimokawaphd correspondenceregardingtolerabilityofcoronavirusdisease2019vaccinesbnt162b2andmrna1273inpatientswiththymicepithelialtumors
_version_ 1718400648774418432